Annexon (ANNX) Interest Expenses (2019 - 2026)
Annexon's (ANNX) quarterly Interest Expenses came in at $32.0 million in Q1 2026, up 129.1% year-on-year from $14.0 million in Q1 2025, and up 85.47% quarter-over-quarter from $17.2 million in Q4 2025.
Annexon (ANNX) Interest Expenses (2019 - 2026) Analysis & Trends
Annexon's Interest Expenses history runs 8 years deep, the most recent figure standing at $32.0 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 129.1% year-over-year to $32.0 million in Q1 2026; TTM through Mar 2026 was $32.0 million, a 129.1% increase from a year earlier, with the FY2025 full-year figure at $224.9 million, up 24.28% from the prior year.
- Interest Expenses grew to $32.0 million in Q1 2026 per ANNX's latest filing, from $17.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $130.9 million in Q4 2023 and bottomed at $3.3 million in Q4 2022.
- The 5-year median for Interest Expenses is $32.0 million (2026), against an average of $32.7 million.
- Across the five-year window, Interest Expenses jumped 3833.28% in 2023 and slumped 96.9% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $3.3 million in 2022, then soared by 3833.28% to $130.9 million in 2023, then slumped by 96.9% to $4.1 million in 2024, then jumped by 324.59% to $17.2 million in 2025, then surged by 85.47% to $32.0 million in 2026.
- Per Business Quant, the three latest ANNX Interest Expenses figures stand at $32.0 million (Q1 2026), $17.2 million (Q4 2025), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | 31.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.96 Mn |
| Mar 31, 2026 | 31.96 Mn |
| Dec 31, 2025 | 17.23 Mn |
| Dec 31, 2025 | 17.23 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 8.18 Mn |
| Jun 30, 2025 | 8.18 Mn |
| Mar 31, 2025 | 13.95 Mn |
| Mar 31, 2025 | 13.95 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 30, 2024 | 39.58 Mn |
| Sep 30, 2024 | 39.58 Mn |
| Jun 30, 2024 | 40.79 Mn |
| Jun 30, 2024 | 40.79 Mn |
| Mar 31, 2024 | 42.01 Mn |
| Mar 31, 2024 | 42.01 Mn |
| Dec 31, 2023 | 130.94 Mn |
| Dec 31, 2023 | 130.94 Mn |